NO20080739L - Fremgangsmater for behandling av Epileptogenese - Google Patents
Fremgangsmater for behandling av EpileptogeneseInfo
- Publication number
- NO20080739L NO20080739L NO20080739A NO20080739A NO20080739L NO 20080739 L NO20080739 L NO 20080739L NO 20080739 A NO20080739 A NO 20080739A NO 20080739 A NO20080739 A NO 20080739A NO 20080739 L NO20080739 L NO 20080739L
- Authority
- NO
- Norway
- Prior art keywords
- group
- alkyl
- methods
- phenyl
- optionally substituted
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
Det beskrives metoder for å tilveiebringe neuroproteksjon omfattende administrering til et individ som trenger det av en terapeutisk effektiv mengde av en forbindelse valgt fra gruppen bestående av formel (I) og formel (II), eller et farmasøytisk akseptabelt salt eller en ester derav; der X er ett til fem halogenatomer valgt fra gruppen bestående av fluor, klor, brom og jod; R1-R6 er uavhengig valgt fra gruppen bestående av hydrogen og C1-4 alkyl; der C1-4 alkyl eventuelt er substituert med fenyl (der fenyl eventuelt er substituert med substituenter uavhengig valgt fra gruppen bestående av halogen, C1-4 alkyl, C1-4 alkoksy, amino, nitro og cyano). I II
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69862505P | 2005-07-12 | 2005-07-12 | |
| PCT/US2006/026277 WO2007008551A2 (en) | 2005-07-12 | 2006-07-07 | Use of 2-phenyl-l, 2-ethanedi0l-(di) carbamates for treating epileptogenesis and epilepsy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20080739L true NO20080739L (no) | 2008-04-10 |
Family
ID=37637731
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20080739A NO20080739L (no) | 2005-07-12 | 2008-02-11 | Fremgangsmater for behandling av Epileptogenese |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20070021501A1 (no) |
| EP (1) | EP1906946A2 (no) |
| JP (1) | JP2009501223A (no) |
| KR (1) | KR20080028485A (no) |
| CN (1) | CN101309680A (no) |
| AR (1) | AR054550A1 (no) |
| AU (1) | AU2006269462A1 (no) |
| BR (1) | BRPI0613010A2 (no) |
| CA (1) | CA2615127A1 (no) |
| EA (1) | EA200800295A1 (no) |
| EC (1) | ECSP088172A (no) |
| IL (1) | IL188728A0 (no) |
| NO (1) | NO20080739L (no) |
| TW (1) | TW200744575A (no) |
| WO (1) | WO2007008551A2 (no) |
| ZA (1) | ZA200801402B (no) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102088990A (zh) * | 2008-05-16 | 2011-06-08 | 阿尔伯维塔公司 | 癫痫的治疗 |
| US8609849B1 (en) | 2010-11-30 | 2013-12-17 | Fox Chase Chemical Diversity Center, Inc. | Hydroxylated sulfamides exhibiting neuroprotective action and their method of use |
| EP2968210A4 (en) | 2013-03-12 | 2016-12-28 | Bio-Pharm Solutions Co Ltd | PHENYL ACARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING PEDIATRIC EPILEPSY AND EPILEPSY-MEDIATED SYNDROME |
| US8652527B1 (en) | 2013-03-13 | 2014-02-18 | Upsher-Smith Laboratories, Inc | Extended-release topiramate capsules |
| US9101545B2 (en) | 2013-03-15 | 2015-08-11 | Upsher-Smith Laboratories, Inc. | Extended-release topiramate capsules |
| KR102481631B1 (ko) * | 2015-08-24 | 2022-12-27 | 조게닉스 인터내셔널 리미티드 | 펜플루라민을 사용하여 레녹스-가스토 증후군을 치료하는 방법 |
| BR112018067663B1 (pt) | 2016-02-29 | 2023-01-10 | Bio-Pharm Solutions Co., Ltd | Compostos derivados de sulfamato, seus usos e composição farmacêutica |
| US20190022166A1 (en) * | 2017-07-18 | 2019-01-24 | Creative Bio-Peptides Inc. | Oral anti-inflammatory peptides to treat epilepsy, seizures and cns disorders |
| CN109920550A (zh) * | 2018-12-25 | 2019-06-21 | 天津大学 | 一种基于dMRI研究青少年肌阵挛性癫痫的方法 |
| CN115501344A (zh) * | 2022-09-29 | 2022-12-23 | 重庆医科大学 | 一种铁螯合剂的应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3313692A (en) * | 1958-04-21 | 1967-04-11 | Armour Pharma | Method of inducing calming and muscle relaxation with carbamates |
| US3265728A (en) * | 1962-07-18 | 1966-08-09 | Armour Pharma | Substituted phenethyl carbamates |
| US5698588A (en) * | 1996-01-16 | 1997-12-16 | Yukong Limited | Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol |
| AU3304997A (en) * | 1996-05-31 | 1998-01-05 | Southern Illinois University | Methods of modulating aspects of brain neural plasticity by vagus nerve stimulation |
| ATE244564T1 (de) * | 1999-02-09 | 2003-07-15 | Univ Virginia | Felbamat-derivate |
| JP4276839B2 (ja) * | 2001-02-27 | 2009-06-10 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | 双極性障害の予防もしくは治療における使用のためのカルバメート化合物 |
| KR100946944B1 (ko) * | 2001-02-27 | 2010-03-15 | 오르토-맥네일 파마슈티칼, 인코퍼레이티드 | 양극성 장애의 예방 또는 치료용 카바메이트 화합물 |
-
2006
- 2006-07-06 US US11/481,626 patent/US20070021501A1/en not_active Abandoned
- 2006-07-07 EP EP06786434A patent/EP1906946A2/en not_active Withdrawn
- 2006-07-07 JP JP2008521432A patent/JP2009501223A/ja not_active Withdrawn
- 2006-07-07 KR KR1020087003269A patent/KR20080028485A/ko not_active Application Discontinuation
- 2006-07-07 EA EA200800295A patent/EA200800295A1/ru unknown
- 2006-07-07 WO PCT/US2006/026277 patent/WO2007008551A2/en active Application Filing
- 2006-07-07 CN CNA2006800333910A patent/CN101309680A/zh active Pending
- 2006-07-07 BR BRPI0613010-0A patent/BRPI0613010A2/pt not_active IP Right Cessation
- 2006-07-07 CA CA002615127A patent/CA2615127A1/en not_active Abandoned
- 2006-07-07 AU AU2006269462A patent/AU2006269462A1/en not_active Abandoned
- 2006-07-11 AR ARP060102976A patent/AR054550A1/es not_active Application Discontinuation
- 2006-07-11 TW TW095125162A patent/TW200744575A/zh unknown
-
2008
- 2008-01-10 IL IL188728A patent/IL188728A0/en unknown
- 2008-02-11 ZA ZA200801402A patent/ZA200801402B/xx unknown
- 2008-02-11 NO NO20080739A patent/NO20080739L/no not_active Application Discontinuation
- 2008-02-12 EC EC2008008172A patent/ECSP088172A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL188728A0 (en) | 2008-11-03 |
| US20070021501A1 (en) | 2007-01-25 |
| CN101309680A (zh) | 2008-11-19 |
| WO2007008551A2 (en) | 2007-01-18 |
| JP2009501223A (ja) | 2009-01-15 |
| EA200800295A1 (ru) | 2008-12-30 |
| ECSP088172A (es) | 2008-03-26 |
| BRPI0613010A2 (pt) | 2010-12-14 |
| TW200744575A (en) | 2007-12-16 |
| AU2006269462A1 (en) | 2007-01-18 |
| KR20080028485A (ko) | 2008-03-31 |
| ZA200801402B (en) | 2009-10-28 |
| EP1906946A2 (en) | 2008-04-09 |
| AR054550A1 (es) | 2007-06-27 |
| WO2007008551A3 (en) | 2008-06-19 |
| CA2615127A1 (en) | 2007-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20080739L (no) | Fremgangsmater for behandling av Epileptogenese | |
| NO20080738L (no) | Fremgangsmater for neurobeskyttelse | |
| NO20071921L (no) | Fremgangsmater for behandling av epileptogenese og epilepsi | |
| NO20064251L (no) | Benzamidazolderivater og anvendelse derav | |
| AR054524A1 (es) | Metodos y formas de dosificacion para reducir los efectos secundarios de compuestos de carbamato | |
| EA200701536A1 (ru) | Способы контроля интервала qt | |
| NO20080877L (no) | Fremgangsmater for behandling av substansrelaterte forstyrrelser | |
| NO20072444L (no) | Karbamatforbindelser for anvendelse i behandling av neurodegenerative forstyrrelser | |
| NO20091658L (no) | Fremgangsmate for behandling av koleitt og vestibulaere lidelser | |
| IL157590A0 (en) | Carbamate compounds for use in preventing or treating bipolar disorder | |
| RS67603A (en) | Carbamate compounds for use in the treatment of pain | |
| ATE555103T1 (de) | Umwandlung von 2-pyrazolinen in pyrazole mithilfe von bromin | |
| HK1062270A1 (en) | Carbamate compounds for use in preventing or treating anxiety disorders | |
| NO20033801L (no) | Karbamatforbindelser for anvendelse ved forebygging eller behandling av psykotiske forstyrrelser | |
| CO6160292A2 (es) | Metodos de tratamiento de transtornos de comportamiento perturbador 877 | |
| EA200700322A1 (ru) | Оксазолидиноны, содержащие оксиндолы, в качестве антибактериальных агентов | |
| NO20040176L (no) | Karbamatforbindelser for anvendelse ved prevensjon eller terapi av neuropatisk smerte og kluster- og migrenehodepineassosiert smerte | |
| MY136733A (en) | Carbamate compounds for use in preventing or treating psychotic disorders | |
| CY1110672T1 (el) | Χρηση των 2- φαινυλ-1,2-αιθανοδιολης- (δι) καρβαμικων για θεραπεια επιληπτογενεσης |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |